Northway Biotech
Tomas Bubinas has a significant work experience spanning over several companies. Tomas started their career at Coopers & Lybrand in 1994 as an Associate and Supervisor, and then became a Supervisor from 1997 to 1999. Tomas then worked at PricewaterhouseCoopers as a Manager and Senior Manager from 1999 to 2001. In 2002, they joined Sicor as a Finance Director for Sicor Biotech until 2004. Bubinas then moved to Teva Pharmaceuticals and served as the CFO for Teva Baltics from 2004 to 2010. Tomas later became the Senior Director at Teva Biopharmaceuticals from 2010 to 2012. Finally, in 2013, Bubinas joined Biotechpharma UAB as the Chief Operating Officer.
Tomas Bubinas holds a Master of Science degree in Economics from Vilnius University, which they obtained from 1988 to 1993. Tomas also pursued an Executive Master of Business Administration (EMBA) at the Baltic Management Institute from 2004 to 2005. Additionally, they have obtained certifications such as Certified Internal Auditor (CIA), Chartered Certified Accountant (ACCA), and Lithuanian sworn auditor from the respective institutions.
This person is not in any offices
Northway Biotech
Northway Biotech is a Contract Development and Manufacturing Organization (CDMO) located in Waltham, MA, USA, and Vilnius, Lithuania, EU. Extensive expertise in drug substance and drug product development, as well as GMP compliant manufacturing, makes us exceptionally well-versed in all aspects of the biopharmaceutical value chain – from gene to drug manufacturing in microbial and mammalian expressions systems. Our customers appreciate our ability to react rapidly to unexpected project changes, adjusting timelines, and availability of additional capabilities to meet our customers' evolving needs. We are deeply invested in providing high-quality, world-class contract development and manufacturing services with vast flexibility and responsiveness backed by a strong foundation in science and technology innovation. Northway Biotech end-to-end services include: Cell Line (Mammalian & Microbial) Development Analytical Methods Development Formulation Development Upstream & Downstream Process Development (USP & DSP) cGMP Manufacturing of Biologics & Biosimilars (Drug Substance, Drug Product) cGMP Master and Working Cell Bank Manufacturing cGMP pDNA Manufacturing Fill & Finish (F&F) Quality Assurance, Quality Control, and Regulatory CMC Support